Affinity Asset Advisors, LLC Morphic Holding, Inc. Transaction History

Affinity Asset Advisors, LLC

$579 Million
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$26.12 - $34.07 $667,966 - $871,272	25,573 Added 11.37%	250,573 $8.54 Million
Q1 2024 May 14, 2024	BUY	$26.64 - $40.31 $4.86 Million - $7.35 Million	182,330 Added 427.3%	225,000 $7.92 Million
Q4 2023 Feb 13, 2024	SELL	$19.95 - $31.0 $4.54 Million - $7.05 Million	-227,330 Reduced 84.2%	42,670 $1.23 Million
Q3 2023 Nov 14, 2023	BUY	$21.33 - $59.42 $1.45 Million - $4.05 Million	68,113 Added 33.74%	270,000 $6.19 Million
Q2 2023 Aug 14, 2023	BUY	$34.33 - $62.11 $2.27 Million - $4.1 Million	66,024 Added 48.6%	201,887 $11.6 Million
Q1 2023 May 15, 2023	SELL	$26.01 - $48.69 $3.77 Million - $7.06 Million	-145,058 Reduced 51.64%	135,863 $5.11 Million
Q4 2022 Feb 13, 2023	BUY	$24.14 - $30.37 $3.25 Million - $4.08 Million	134,430 Added 91.77%	280,921 $7.51 Million
Q3 2022 Nov 14, 2022	SELL	$22.23 - $33.37 $1.54 Million - $2.31 Million	-69,232 Reduced 32.09%	146,491 $4.15 Million
Q2 2022 Aug 12, 2022	SELL	$19.74 - $43.01 $4.93 Million - $10.7 Million	-249,931 Reduced 53.67%	215,723 $4.68 Million
Q1 2022 May 13, 2022	BUY	$36.25 - $52.02 $2.41 Million - $3.45 Million	66,352 Added 16.62%	465,654 $18.7 Million
Q4 2021 Feb 11, 2022	BUY	$43.27 - $65.72 $5.56 Million - $8.45 Million	128,547 Added 47.48%	399,302 $18.9 Million
Q3 2021 Nov 12, 2021	BUY	$53.61 - $67.5 $1.32 Million - $1.66 Million	24,554 Added 9.97%	270,755 $15.3 Million
Q2 2021 Aug 13, 2021	BUY	$45.13 - $64.99 $2.31 Million - $3.33 Million	51,201 Added 26.26%	246,201 $14.1 Million
Q1 2021 May 14, 2021	BUY	$29.77 - $84.85 $3.8 Million - $10.8 Million	127,500 Added 188.89%	195,000 $12.3 Million
Q4 2020 Feb 12, 2021	BUY	$25.66 - $34.55 $1.73 Million - $2.33 Million	67,500 New	67,500 $2.27 Million

Others Institutions Holding MORF

# of Institutions

Shares Held

4.7M

Call Options Held

Put Options Held

View Full List

About Morphic Holding, Inc.

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $2.19B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

More about MORF

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Affinity Asset Advisors, LLC with notifications on news.

Account